Serum Levels of S-Glutathionylated Proteins as a Risk-Marker for Arteriosclerosis Obliterans-Reference-Cited by-同舟云学术

Serum Levels of S-Glutathionylated Proteins as a Risk-Marker for Arteriosclerosis Obliterans

Published:2007 Issue:1 Volume:71 Page:100-105
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Nonaka Kazuki¹,Kume Noriaki²,Urata Yoshishige¹,Seto Shinji³,Kohno Takaaki³,Honda Sumihisa³,Ikeda Soji³,Muroya Takahiro⁴,Ikeda Yosihiko⁵,Ihara Yoshito¹,Kita Toru²,Kondo Takahito¹

Affiliation:

1. Department of Biochemistry and Molecular Biology in Disease, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences

2. Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University

3. Department of Radiation Epidemiology, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences

4. Department of Internal Medicine, Nagasaki University Graduate School of Biomedical Sciences

5. Tagawa Municipal Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://www.jstage.jst.go.jp/article/circj/71/1/71_1_100/_pdf

Reference28 articles.

1. Increase in Peripheral Blood Flow by Intravenous Administration of Prostaglandin E1 in Patients with Peripheral Arterial Disease, Accompanied by Up-Regulation of Hepatocyte Growth Factor

2. Safety Evaluation of Clinical Gene Therapy Using Hepatocyte Growth Factor to Treat Peripheral Arterial Disease

3. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular and molecular biology of posttranslational modifications in cardiovascular disease;Biomedicine & Pharmacotherapy;2024-10

2. Raman spectroscopic analysis of human serum samples of convalescing COVID-19 positive patients;Clinical Spectroscopy;2023-12

3. Changes in Hemoglobin Properties in Complex with Glutathione and after Glutathionylation;International Journal of Molecular Sciences;2023-08-31

4. Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies;Signal Transduction and Targeted Therapy;2023-05-27

5. Origin of Elevated S-Glutathionylated GAPDH in Chronic Neurodegenerative Diseases;International Journal of Molecular Sciences;2023-03-14